Reuters logo
BRIEF-Audentes Therapeutics qtrly loss per share $0.83
May 11, 2017 / 12:23 PM / 6 months ago

BRIEF-Audentes Therapeutics qtrly loss per share $0.83

May 11 (Reuters) - Audentes Therapeutics Inc

* Audentes therapeutics reports first quarter 2017 financial results and provides corporate update

* Qtrly loss per share $ 0.83

* Q1 earnings per share view $-0.92 -- Thomson Reuters I/B/E/S

* Audentes therapeutics inc - research and development expenses were $14.6 million for q1 of 2017 compared to $7.9 million for same period in 2016

* Audentes therapeutics inc - as of march 31, 2017, audentes had cash, cash equivalents and short-term investments of $81.7 million

* Audentes therapeutics inc - current cash, cash equivalents and marketable securities are planned to fund operations into late 2019

* Audentes therapeutics-on track to file inds to evaluate systemic administration of at982 for treatment of pompe disease, at307 for treatment of cpvt Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below